. 1984 Jun;25(6):787.
Combined Interferon-α2, Rimantadine Hydrochloride, and Ribavirin Inhibition of Influenza Virus Replication In Vitro
Frederick G Hayden
1, Anatoli N Schlepushkin
1, Nina L Pushkarskaya
1
Frederick G Hayden
1Departments of Internal Medicine and Pathology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, and D. I. Ivanovsky Institute of Virology, Moscow, USSR
Find articles by Frederick G Hayden
Anatoli N Schlepushkin
1Departments of Internal Medicine and Pathology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, and D. I. Ivanovsky Institute of Virology, Moscow, USSR
Find articles by Anatoli N Schlepushkin
Nina L Pushkarskaya
1Departments of Internal Medicine and Pathology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, and D. I. Ivanovsky Institute of Virology, Moscow, USSR
Find articles by Nina L Pushkarskaya
1Departments of Internal Medicine and Pathology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, and D. I. Ivanovsky Institute of Virology, Moscow, USSR
PMCID: PMC185646
This corrects the article "Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro." on page 56.